BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10542290)

  • 21. Identification of PU.1 and Sp1 as essential transcriptional factors for the promoter activity of mouse tec gene.
    Honda H; Ozawa K; Yazaki Y; Hirai H
    Biochem Biophys Res Commun; 1997 May; 234(2):376-81. PubMed ID: 9177279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PU.1 regulates the expression of the vav proto-oncogene.
    Denkinger DJ; Lambrecht TQ; Cushman-Vokoun AM; Kawahara RS
    J Cell Biochem; 2002; 84(4):772-83. PubMed ID: 11835402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter.
    Ying H; Chang JF; Parnes JR
    J Immunol; 1998 Mar; 160(5):2287-96. PubMed ID: 9498769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cytokines and transcriptional regulators involved.
    Dusi S; Donini M; Lissandrini D; Mazzi P; Bianca VD; Rossi F
    Eur J Immunol; 2001 Mar; 31(3):929-38. PubMed ID: 11241298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AP-1 is essential for p67(phox) promoter activity.
    Gauss KA; Bunger PL; Quinn MT
    J Leukoc Biol; 2002 Jan; 71(1):163-72. PubMed ID: 11781392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus.
    Eichbaum QG; Iyer R; Raveh DP; Mathieu C; Ezekowitz RA
    J Exp Med; 1994 Jun; 179(6):1985-96. PubMed ID: 8195721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulation of mouse mu opioid receptor gene by PU.1.
    Hwang CK; Kim CS; Choi HS; McKercher SR; Loh HH
    J Biol Chem; 2004 May; 279(19):19764-74. PubMed ID: 14998994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional control of Pactolus: evidence of a negative control region and comparison with its evolutionary paralogue, CD18 (beta2 integrin).
    Hale JS; Dahlem TJ; Margraf RL; Debnath I; Weis JJ; Weis JH
    J Leukoc Biol; 2006 Aug; 80(2):383-98. PubMed ID: 16735694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PU.1 is involved in the regulation of B lineage-associated and developmental stage-dependent expression of the germinal center-associated DNA primase GANP.
    EL-Gazzar MA; Maeda K; Nomiyama H; Nakao M; Kuwahara K; Sakaguchi N
    J Biol Chem; 2001 Dec; 276(51):48000-8. PubMed ID: 11641399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene.
    Rehli M; Poltorak A; Schwarzfischer L; Krause SW; Andreesen R; Beutler B
    J Biol Chem; 2000 Mar; 275(13):9773-81. PubMed ID: 10734131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
    Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
    J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.
    Okuno Y; Huang G; Rosenbauer F; Evans EK; Radomska HS; Iwasaki H; Akashi K; Moreau-Gachelin F; Li Y; Zhang P; Göttgens B; Tenen DG
    Mol Cell Biol; 2005 Apr; 25(7):2832-45. PubMed ID: 15767686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding site.
    Smith MF; Carl VS; Lodie T; Fenton MJ
    J Biol Chem; 1998 Sep; 273(37):24272-9. PubMed ID: 9727052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PU.1 and USF are required for macrophage-specific mannose receptor promoter activity.
    Egan BS; Lane KB; Shepherd VL
    J Biol Chem; 1999 Mar; 274(13):9098-107. PubMed ID: 10085160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S; Atchison ML; Fenton MJ
    J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex.
    Wezensky SJ; Hanks TS; Wilkison MJ; Ammons MC; Siemsen DW; Gauss KA
    Gene; 2010 Feb; 452(1):22-34. PubMed ID: 20025940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-specific transcription of leukotriene C(4) synthase involves a Kruppel-like transcription factor and Sp1.
    Zhao JL; Austen KF; Lam BK
    J Biol Chem; 2000 Mar; 275(12):8903-10. PubMed ID: 10722737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
    Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
    J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
    Marecki S; Riendeau CJ; Liang MD; Fenton MJ
    J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.